The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment.
Blood Cancer J
; 11(8): 138, 2021 08 02.
Article
in En
| MEDLINE
| ID: mdl-34341335
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antibodies, Neutralizing
/
COVID-19 Vaccines
/
SARS-CoV-2
/
COVID-19
/
Antibodies, Viral
/
Multiple Myeloma
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Blood Cancer J
Year:
2021
Document type:
Article
Affiliation country:
Greece
Country of publication:
United States